SEC Form 4 · accession 0001225208-26-007377
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Annette Bruls
Officer — CVP, EMEACLA
Period of report
Aug 28, 2026
Accepted (ET)
Aug 28, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 28, 2026 | S | 2,644 | $89.98 | D | 17,984 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.